• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Correction to: Postoperative Adjuvant Transarterial Infusion Chemotherapy with FOLFOX Could Improve Outcomes of Hepatocellular Carcinoma Patients with Microvascular Invasion: A Preliminary Report of a Phase III, Randomized Controlled Clinical Trial.

作者信息

Li Shaohua, Mei Jie, Wang Qiaoxuan, Guo Zhixing, Lu Lianghe, Ling Yihong, Xu Li, Chen Minshan, Zheng Lie, Lin Wenping, Zou Jingwen, Wen Yuhua, Wei Wei, Guo Rongping

机构信息

Department of Liver Surgery, Sun Yat-sen University Cancer Center, Guangzhou, Guangdong, People's Republic of China.

State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer 3Medicine, Guangzhou, Guangdong, People's Republic of China.

出版信息

Ann Surg Oncol. 2021 Dec;28(Suppl 3):874. doi: 10.1245/s10434-021-09813-2.

DOI:10.1245/s10434-021-09813-2
PMID:33839979
Abstract
摘要

相似文献

1
Correction to: Postoperative Adjuvant Transarterial Infusion Chemotherapy with FOLFOX Could Improve Outcomes of Hepatocellular Carcinoma Patients with Microvascular Invasion: A Preliminary Report of a Phase III, Randomized Controlled Clinical Trial.对《FOLFOX术后辅助经动脉灌注化疗可改善伴有微血管侵犯的肝细胞癌患者的预后：一项III期随机对照临床试验的初步报告》的勘误
Ann Surg Oncol. 2021 Dec;28(Suppl 3):874. doi: 10.1245/s10434-021-09813-2.
2
Postoperative Adjuvant Transarterial Infusion Chemotherapy with FOLFOX Could Improve Outcomes of Hepatocellular Carcinoma Patients with Microvascular Invasion: A Preliminary Report of a Phase III, Randomized Controlled Clinical Trial.术后经肝动脉灌注化疗联合 FOLFOX 方案治疗可改善伴有微血管侵犯的肝细胞癌患者的预后：一项 III 期随机对照临床试验的初步报告。
Ann Surg Oncol. 2020 Dec;27(13):5183-5190. doi: 10.1245/s10434-020-08601-8. Epub 2020 May 16.
3
Postoperative adjuvant transarterial chemoembolization improves the prognosis of hepatocellular carcinoma patients with microvascular invasion: a systematic review and meta-analysis.术后辅助经动脉化疗栓塞改善微血管侵犯肝细胞癌患者的预后：一项系统评价和荟萃分析
Acta Radiol. 2020 Jun;61(6):723-731. doi: 10.1177/0284185119878357. Epub 2019 Oct 8.
4
Tumor Size Affects Efficacy of Adjuvant Transarterial Chemoembolization in Patients with Hepatocellular Carcinoma and Microvascular Invasion.肿瘤大小影响伴有微血管侵犯的肝细胞癌患者辅助经动脉化疗栓塞的疗效。
Oncologist. 2019 Apr;24(4):513-520. doi: 10.1634/theoncologist.2018-0305. Epub 2018 Dec 14.
5
Oxaliplatin-Based Adjuvant Chemotherapy for Rectal Cancer After Preoperative Chemoradiotherapy (ADORE): Long-Term Results of a Randomized Controlled Trial.奥沙利铂为基础的辅助化疗在术前放化疗后直肠癌（ADORE）：随机对照试验的长期结果。
J Clin Oncol. 2019 Nov 20;37(33):3111-3123. doi: 10.1200/JCO.19.00016. Epub 2019 Oct 8.
6
Upfront radical surgery with total mesorectal excision followed by adjuvant FOLFOX chemotherapy for locally advanced rectal cancer (TME-FOLFOX): an open-label, multicenter, phase II randomized controlled trial.局部进展期直肠癌行全直肠系膜切除术联合辅助 FOLFOX 化疗的 upfront 根治性手术（TME-FOLFOX）：一项开放标签、多中心、二期随机对照临床试验。
Trials. 2020 Apr 7;21(1):320. doi: 10.1186/s13063-020-04266-6.
7
Postoperative hepatic arterial chemotherapy in high-risk patients as adjuvant treatment after resection of colorectal liver metastases - a randomized phase II/III trial - PACHA-01 (NCT02494973).结直肠肝转移切除术后高危患者辅助治疗的术后肝动脉化疗-一项随机 II/III 期试验-PACHA-01（NCT02494973）。
BMC Cancer. 2018 Aug 6;18(1):787. doi: 10.1186/s12885-018-4697-7.
8
Oxaliplatin, fluorouracil, and leucovorin versus fluorouracil and leucovorin as adjuvant chemotherapy for locally advanced rectal cancer after preoperative chemoradiotherapy (ADORE): an open-label, multicentre, phase 2, randomised controlled trial.奥沙利铂、氟尿嘧啶和亚叶酸钙与氟尿嘧啶和亚叶酸钙作为术前放化疗后局部进展期直肠癌的辅助化疗（ADORE）：一项开放标签、多中心、2 期、随机对照临床试验。
Lancet Oncol. 2014 Oct;15(11):1245-53. doi: 10.1016/S1470-2045(14)70377-8. Epub 2014 Sep 4.
9
The effects of several postoperative adjuvant therapies for hepatocellular carcinoma patients with microvascular invasion after curative resection: a systematic review and meta-analysis.根治性切除术后微血管侵犯的肝细胞癌患者几种术后辅助治疗的效果：一项系统评价和荟萃分析
Cancer Cell Int. 2021 Feb 6;21(1):92. doi: 10.1186/s12935-021-01790-6.
10
Neoadjuvant FOLFOX 4 versus FOLFOX 4 with Cetuximab versus immediate surgery for high-risk stage II and III colon cancers: a multicentre randomised controlled phase II trial--the PRODIGE 22--ECKINOXE trial.新辅助FOLFOX 4方案对比联合西妥昔单抗的FOLFOX 4方案以及直接手术治疗高危II期和III期结肠癌：一项多中心随机对照II期试验——PRODIGE 22——ECKINOXE试验
BMC Cancer. 2015 Jul 10;15:511. doi: 10.1186/s12885-015-1507-3.

引用本文的文献

1
First-line hepatic arterial infusion chemotherapy plus lenvatinib and PD-(L)1 inhibitors versus systemic chemotherapy alone or with PD-(L)1 inhibitors in unresectable intrahepatic cholangiocarcinoma.一线肝动脉灌注化疗联合仑伐替尼和 PD-(L)1 抑制剂与单独全身化疗或联合 PD-(L)1 抑制剂治疗不可切除的肝内胆管癌。
J Cancer Res Clin Oncol. 2024 Jun 18;150(6):309. doi: 10.1007/s00432-024-05795-2.
2
Hepatic Artery Infusion Chemotherapy Sequential Hepatic Artery Embolization Combined with Operation in the Treatment of Recurrent Massive Hepatocellular Carcinoma Achieved Pathological Complete Response: A Case Report.肝动脉灌注化疗序贯肝动脉栓塞联合手术治疗复发性巨块型肝细胞癌获病理完全缓解：1例报告
Pharmgenomics Pers Med. 2023 Nov 1;16:949-958. doi: 10.2147/PGPM.S426791. eCollection 2023.